 |
|
|
| |
Long Term (4 Year) Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) Treatment in HBeAg-Positive Patients (HBeAg+) with Chronic Hepatitis B (Study 103)
|
| |
| |
Reported by Jules Levin
AASLD Oct 31 2010 Boston
E J Heathcote1, E J Gane2, R A de Man3, S Chan4, J George5, N Tsai6, P Marcellin7, A Snow-Lampart8, D H Coombs8, E Mondou8, J Anderson8
1University of Toronto, Toronto, ON, Canada; 2Middlemore Hospital, Auckland, New Zealand; 3Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands; 4New York Hospital at Queens, Flushing, NY, USA;
5Storr Liver Unit, Westmead Hospital and University of Sydney, Sydney, NSW, Australia; 6University of Hawaii, Honolulu, HI, USA; 7Hopital Beaujon, University of Paris, Clichy, France; 8Gilead Sciences, Durham, NC, USA.
|
| |
|
|
|
|
|
